{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:32:04Z","timestamp":1794468724530,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol. Neurodegener. Adv."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Natural killer (NK) cells are key effector lymphoid cells involved in both innate and adaptive immunity and are capable of clearing abnormally aggregated \u03b1-synuclein (\u03b1Syn). In preclinical Parkinson\u2019s disease (PD) models, NK cell depletion worsens motor deficits and increases insoluble \u03b1Syn accumulation, suggesting a neuroprotective role. However, the therapeutic potential of NK cell transfer in modulating \u03b1Syn pathology and neurodegeneration remains unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To assess the efficacy of NK cell therapy, we administered biweekly systemic injections of untouched NK cells isolated from B6C3H donor mice into 2-month-old presymptomatic homozygous M83 transgenic mice injected with human \u03b1Syn preformed fibrils. Neurological function was assessed via clasping behavior and clinical scoring. \u03b1Syn pathology and dopaminergic neurodegeneration were evaluated via immunohistochemistry. CyTOF-based immune profiling and multiplex ELISA were performed to characterize central and peripheral immune responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Adoptive NK cell transfers improved motor function and reduced \u03b1Syn pathology in a region- and dose-dependent manner, with significant reductions in phosphorylated-\u03b1Syn inclusions\u00a0and tyrosine hydroxylase-positive neuronal loss in the substantia nigra. NK cell transfer modulated the CNS immune landscape by reducing CD11b\n                      <jats:sup>+<\/jats:sup>\n                      CD45\n                      <jats:sup>high<\/jats:sup>\n                      and MHCII\n                      <jats:sup>+<\/jats:sup>\n                      activated microglial, CD4\u207a T cells, and neutrophil infiltration, while promoting CD19\n                      <jats:sup>+<\/jats:sup>\n                      B and CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells. Similar immunomodulatory effects were observed in the periphery, including restoration of follicular B cells and reduced neutrophil frequencies. Mechanistically, \u03b1Syn exposure downregulated activating NK ligands and upregulated inhibitory receptor ligand mQa1b, along with p21 induction in microglia, suggesting a senescence-associated, immune-evasive phenotype that may contribute to reduced therapeutic efficacy at later disease stages.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study provides direct evidence of NK cells exerting neuroprotective and immunomodulatory effects in a preclinical model of synucleinopathy. These findings support NK cell transfer as a novel therapeutic strategy for PD and related neurodegenerative disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s44477-025-00006-9","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:26:38Z","timestamp":1764249998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adoptive NK cell transfer confers neuroprotection by attenuating neuroinflammation and alpha-synuclein pathology in a mouse model of synucleinopathy"],"prefix":"10.1186","volume":"1","author":[{"given":"Adetutu","family":"Adebowale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Ha","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaegwon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Joon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan","family":"Gresham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jina","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"9996","key":"6_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386(9996):896\u2013912.","journal-title":"Lancet"},{"issue":"11","key":"6_CR2","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. \u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci. 1998;95(11):6469\u201373.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"6_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/mds.25187","volume":"28","author":"D Sulzer","year":"2013","unstructured":"Sulzer D, Surmeier DJ. Neuronal vulnerability, pathogenesis, and Parkinson\u2019s disease. Mov Disord. 2013;28(6):715\u201324.","journal-title":"Mov Disord"},{"issue":"10291","key":"6_CR4","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Lancet"},{"issue":"6","key":"6_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323(6):548\u201360.","journal-title":"JAMA"},{"issue":"7","key":"6_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AH Schapira","year":"2017","unstructured":"Schapira AH, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017;18(7):435\u201350.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"6_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","volume":"23","author":"M Reale","year":"2009","unstructured":"Reale M, Iarlori C, Thomas A, Gambi D, Perfetti B, Di Nicola M, et al. Peripheral cytokines profile in Parkinson\u2019s disease. Brain Behav Immun. 2009;23(1):55\u201363.","journal-title":"Brain Behav Immun"},{"key":"6_CR8","doi-asserted-by":"crossref","unstructured":"Williams-Gray C. Wijeyekoon R1, Yarnall AJ2, Lawson RA2, Breen DP1, Evans JR1, Cummins GA1, Duncan GW3, Khoo TK4, Burn DJ2, Barker RA1; ICICLE-PD study group. Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD). Mov Disord. 2016;31(7):995\u20131003.","DOI":"10.1002\/mds.26563"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11481-012-9401-0","volume":"8","author":"D B\u00e9raud","year":"2013","unstructured":"B\u00e9raud D, Hathaway HA, Trecki J, Chasovskikh S, Johnson DA, Johnson JA, et al. Microglial activation and antioxidant responses induced by the Parkinson\u2019s disease protein \u03b1-synuclein. J Neuroimmune Pharmacol. 2013;8:94\u2013117.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"8","key":"6_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","volume":"11","author":"Y Baba","year":"2005","unstructured":"Baba Y, Kuroiwa A, Uitti RJ, Wszolek ZK, Yamada T. Alterations of t-lymphocyte populations in Parkinson disease. Parkinsonism Relat Disord. 2005;11(8):493\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"6_CR11","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awab103","volume":"144","author":"GP Williams","year":"2021","unstructured":"Williams GP, Schonhoff AM, Jurkuvenaite A, Gallups NJ, Standaert DG, Harms AS. CD4 t cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Brain. 2021;144(7):2047\u201359.","journal-title":"Brain"},{"issue":"2","key":"6_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad060","volume":"5","author":"KM Scott","year":"2023","unstructured":"Scott KM, Chong YT, Park S, Wijeyekoon RS, Hayat S, Mathews RJ, et al. B lymphocyte responses in Parkinson\u2019s disease and their possible significance in disease progression. Brain Commun. 2023;5(2):fcad060.","journal-title":"Brain Commun"},{"issue":"11","key":"6_CR13","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.4049\/jimmunol.1203401","volume":"190","author":"A Poli","year":"2013","unstructured":"Poli A, Kmiecik J, Domingues O, Hentges F, Blery M, Chekenya M, et al. NK cells in central nervous system disorders. J Immunol. 2013;190(11):5355\u201362.","journal-title":"J Immunol"},{"issue":"8","key":"6_CR14","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.4049\/jimmunol.180.8.5558","volume":"180","author":"CL Small","year":"2008","unstructured":"Small CL, McCormick S, Gill N, Kugathasan K, Santosuosso M, Donaldson N, et al. NK cells play a critical protective role in host defense against acute extracellular Staphylococcus aureus bacterial infection in the lung. J Immunol. 2008;180(8):5558\u201368.","journal-title":"J Immunol"},{"issue":"11","key":"6_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002368","volume":"7","author":"RL Schmidt","year":"2011","unstructured":"Schmidt RL, Filak HC, Lemon JD, Potter TA, Lenz LL. A lysm and SH3-domain containing region of the Listeria monocytogenes p60 protein stimulates accessory cells to promote activation of host NK cells. PLoS Pathog. 2011;7(11):e1002368.","journal-title":"PLoS Pathog"},{"issue":"15","key":"6_CR16","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/onc.2012.206","volume":"32","author":"A Sagiv","year":"2013","unstructured":"Sagiv A, Biran A, Yon M, Simon J, Lowe SW, Krizhanovsky V. Granule exocytosis mediates immune surveillance of senescent cells. Oncogene. 2013;32(15):1971\u20137.","journal-title":"Oncogene"},{"issue":"4","key":"6_CR17","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.4049\/jimmunol.1102002","volume":"188","author":"FB Thoren","year":"2012","unstructured":"Thoren FB, Riise RE, Ousback J, Della Chiesa M, Alsterholm M, Marcenaro E, et al. Human NK cells induce neutrophil apoptosis via an NKp46- and Fas-dependent mechanism. J Immunol. 2012;188(4):1668\u201374.","journal-title":"J Immunol"},{"key":"6_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00377","volume":"3","author":"SN Waggoner","year":"2012","unstructured":"Waggoner SN, Kumar V. Evolving role of 2B4\/CD244 in T and NK cell responses during virus infection. Front Immunol. 2012;3:377.","journal-title":"Front Immunol"},{"issue":"12","key":"6_CR19","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/ni1138","volume":"5","author":"A Martin-Fontecha","year":"2004","unstructured":"Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol. 2004;5(12):1260\u20135.","journal-title":"Nat Immunol"},{"issue":"2","key":"6_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1182\/blood-2004-10-4035","volume":"106","author":"M Vitale","year":"2005","unstructured":"Vitale M, Della Chiesa M, Carlomagno S, Pende D, Arico M, Moretta L, et al. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood. 2005;106(2):566\u201371.","journal-title":"Blood"},{"issue":"2","key":"6_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuron.2018.12.006","volume":"101","author":"Q Li","year":"2019","unstructured":"Li Q, Cheng Z, Zhou L, Darmanis S, Neff NF, Okamoto J, et al. Developmental heterogeneity of microglia and brain myeloid cells revealed by deep single-cell RNA sequencing. Neuron. 2019;101(2):207-23 e10.","journal-title":"Neuron."},{"key":"6_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-019-0393-4","author":"H Van Hove","year":"2019","unstructured":"Van Hove H, Martens L, Scheyltjens I, De Vlaminck K, Pombo Antunes AR, De Prijck S, et al. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat Neurosci. 2019. https:\/\/doi.org\/10.1038\/s41593-019-0393-4.","journal-title":"Nat Neurosci"},{"issue":"1","key":"6_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.parkreldis.2007.05.013","volume":"14","author":"T Mihara","year":"2008","unstructured":"Mihara T, Nakashima M, Kuroiwa A, Akitake Y, Ono K, Hosokawa M, et al. Natural killer cells of Parkinson\u2019s disease patients are set up for activation: a possible role for innate immunity in the pathogenesis of this disease. Parkinsonism Relat Disord. 2008;14(1):46\u201351.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"6_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1447-0594.2011.00740.x","volume":"12","author":"F Niwa","year":"2012","unstructured":"Niwa F, Kuriyama N, Nakagawa M, Imanishi J. Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson\u2019s disease. Geriatr Gerontol Int. 2012;12(1):102\u20137.","journal-title":"Geriatr Gerontol Int"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.2147\/OTT.S134716","volume":"10","author":"L Chen","year":"2017","unstructured":"Chen L, Zuo Y, Zhu L, Zhang Y, Li S, Ma F, et al. Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy. Onco Targets Ther. 2017;10:2569\u201380.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"6_CR26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12974-019-1636-8","volume":"16","author":"RH Earls","year":"2019","unstructured":"Earls RH, Menees KB, Chung J, Barber J, Gutekunst CA, Hazim MG, et al. Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice. J Neuroinflammation. 2019;16(1):250.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"6_CR27","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1073\/pnas.1909110117","volume":"117","author":"RH Earls","year":"2020","unstructured":"Earls RH, Menees KB, Chung J, Gutekunst CA, Lee HJ, Hazim MG, et al. NK cells clear alpha-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of alpha-synucleinopathy. Proc Natl Acad Sci U S A. 2020;117(3):1762\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"6_CR28","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1073\/pnas.1909110117","volume":"117","author":"RH Earls","year":"2020","unstructured":"Earls RH, Menees KB, Chung J, Gutekunst C-A, Lee HJ, Hazim MG, et al. NK cells clear \u03b1-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of \u03b1-synucleinopathy. Proc Natl Acad Sci. 2020;117(3):1762\u201371.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"6_CR29","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1074\/jbc.M008919200","volume":"276","author":"BI Giasson","year":"2001","unstructured":"Giasson BI, Murray IV, Trojanowski JQ, Lee VM. A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem. 2001;276(4):2380\u20136.","journal-title":"J Biol Chem"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-015-0029-4","volume":"10","author":"NJ Rutherford","year":"2015","unstructured":"Rutherford NJ, Sacino AN, Brooks M, Ceballos-Diaz C, Ladd TB, Howard JK, et al. Studies of lipopolysaccharide effects on the induction of alpha-synuclein pathology by exogenous fibrils in transgenic mice. Mol Neurodegener. 2015;10:32.","journal-title":"Mol Neurodegener"},{"key":"6_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-9-29","volume":"9","author":"P Lei","year":"2014","unstructured":"Lei P, Ayton S, Moon S, Zhang Q, Volitakis I, Finkelstein DI, et al. Motor and cognitive deficits in aged tau knockout mice in two background strains. Mol Neurodegener. 2014;9:1\u201312.","journal-title":"Mol Neurodegener"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-62703-520-0_3","volume":"1041","author":"JK Lee","year":"2013","unstructured":"Lee JK, Tansey MG. Microglia isolation from adult mouse brain. Methods Mol Biol. 2013;1041:17\u201323.","journal-title":"Methods Mol Biol"},{"issue":"11","key":"6_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081785","volume":"8","author":"JK Lee","year":"2013","unstructured":"Lee JK, Chung J, Kannarkat GT, Tansey MG. Critical role of regulator G-protein signaling 10 (RGS10) in modulating macrophage M1\/M2 activation. PLoS ONE. 2013;8(11):e81785.","journal-title":"PLoS ONE"},{"issue":"2","key":"6_CR34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2567.2007.02573.x","volume":"121","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Wallace DL, de Lara CM, Ghattas H, Asquith B, Worth A, et al. In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology. 2007;121(2):258\u201365.","journal-title":"Immunology"},{"issue":"8","key":"6_CR35","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1084\/jem.20021847","volume":"197","author":"M Prlic","year":"2003","unstructured":"Prlic M, Blazar BR, Farrar MA, Jameson SC. In vivo survival and homeostatic proliferation of natural killer cells. J Exp Med. 2003;197(8):967\u201376.","journal-title":"J Exp Med"},{"issue":"5562","key":"6_CR36","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1126\/science.1068438","volume":"295","author":"JW Wang","year":"2002","unstructured":"Wang JW, Howson JM, Ghansah T, Desponts C, Ninos JM, May SL, et al. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Science. 2002;295(5562):2094\u20137.","journal-title":"Science"},{"issue":"12","key":"6_CR37","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1097\/01.tp.0000250935.41034.2d","volume":"82","author":"M Ohira","year":"2006","unstructured":"Ohira M, Ohdan H, Mitsuta H, Ishiyama K, Tanaka Y, Igarashi Y, et al. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy. Transplantation. 2006;82(12):1712\u20139.","journal-title":"Transplantation"},{"issue":"9","key":"6_CR38","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/s12276-020-00505-7","volume":"52","author":"RH Earls","year":"2020","unstructured":"Earls RH, Lee JK. The role of natural killer cells in Parkinson\u2019s disease. Exp Mol Med. 2020;52(9):1517\u201325.","journal-title":"Exp Mol Med"},{"issue":"1","key":"6_CR39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12328","volume":"267","author":"R Carapito","year":"2015","unstructured":"Carapito R, Bahram S. Genetics, genomics, and evolutionary biology of NKG2D ligands. Immunol Rev. 2015;267(1):88\u2013116.","journal-title":"Immunol Rev"},{"issue":"10","key":"6_CR40","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1084\/jem.188.10.1841","volume":"188","author":"RE Vance","year":"1998","unstructured":"Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH. Mouse CD94\/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med. 1998;188(10):1841\u20138.","journal-title":"J Exp Med"},{"issue":"1","key":"6_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41531-022-00438-0","volume":"8","author":"D Mamula","year":"2022","unstructured":"Mamula D, Khosousi S, He Y, Lazarevic V, Svenningsson P. Impaired migratory phenotype of CD4(+) T cells in Parkinson\u2019s disease. NPJ Parkinsons Dis. 2022;8(1):171.","journal-title":"NPJ Parkinsons Dis"},{"issue":"2","key":"6_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad060","volume":"5","author":"KM Scott","year":"2023","unstructured":"Scott KM, Chong YT, Park S, Wijeyekoon RS, Hayat S, Mathews RJ, et al. B lymphocyte responses in Parkinson\u2019s disease and their possible significance in disease progression. Brain Commun. 2023;5(2):fcad060.","journal-title":"Brain Commun"},{"key":"6_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.965169","volume":"14","author":"B Santos-Lima","year":"2022","unstructured":"Santos-Lima B, Pietronigro EC, Terrabuio E, Zenaro E, Constantin G. The role of neutrophils in the dysfunction of central nervous system barriers. Front Aging Neurosci. 2022;14:965169.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"6_CR44","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12883-023-03380-7","volume":"23","author":"S Hosseini","year":"2023","unstructured":"Hosseini S, Shafiabadi N, Khanzadeh M, Ghaedi A, Ghorbanzadeh R, Azarhomayoun A, et al. Neutrophil to lymphocyte ratio in Parkinson\u2019s disease: a systematic review and meta-analysis. BMC Neurol. 2023;23(1):333.","journal-title":"BMC Neurol"},{"issue":"7","key":"6_CR45","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of alzheimer\u2019s disease. Cell. 2017;169(7):1276-90 e17.","journal-title":"Cell."},{"issue":"5","key":"6_CR46","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2007.03.017","volume":"26","author":"L Lu","year":"2007","unstructured":"Lu L, Ikizawa K, Hu D, Werneck MB, Wucherpfennig KW, Cantor H. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity. 2007;26(5):593\u2013604.","journal-title":"Immunity"},{"issue":"6","key":"6_CR47","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1073\/pnas.0914732107","volume":"107","author":"JW Leavenworth","year":"2010","unstructured":"Leavenworth JW, Schellack C, Kim HJ, Lu L, Spee P, Cantor H. Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab\u2019)2. Proc Natl Acad Sci U S A. 2010;107(6):2562\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"6_CR48","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.4049\/jimmunol.165.9.4895","volume":"165","author":"E Backstrom","year":"2000","unstructured":"Backstrom E, Chambers BJ, Kristensson K, Ljunggren HG. Direct NK cell-mediated lysis of syngenic dorsal root ganglia neurons in vitro. J Immunol. 2000;165(9):4895\u2013900.","journal-title":"J Immunol"},{"issue":"4","key":"6_CR49","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cell.2018.12.022","volume":"176","author":"AJ Davies","year":"2019","unstructured":"Davies AJ, Kim HW, Gonzalez-Cano R, Choi J, Back SK, Roh SE, et al. Natural killer cells degenerate intact sensory afferents following nerve injury. Cell. 2019;176(4):716-28 e18.","journal-title":"Cell."},{"key":"6_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071694","author":"DK Verma","year":"2021","unstructured":"Verma DK, Seo BA, Ghosh A, Ma SX, Hernandez-Quijada K, Andersen JK, et al. Alpha-synuclein preformed fibrils induce cellular senescence in Parkinson\u2019s disease models. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10071694.","journal-title":"Cells"}],"updated-by":[{"DOI":"10.1186\/s44477-025-00014-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000}}],"container-title":["Molecular Neurodegeneration Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44477-025-00006-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44477-025-00006-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44477-025-00006-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:02:49Z","timestamp":1768579369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s44477-025-00006-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1186\/s44477-025-00006-9","relation":{},"ISSN":["3059-4944"],"issn-type":[{"value":"3059-4944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s44477-025-00014-9","URL":"https:\/\/doi.org\/10.1186\/s44477-025-00014-9","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were performed in accordance with NIH guidelines and with the approval of the University of Georgia Institutional Animal Care and Use Committee prior to all animal-related studies (IACUC protocol AUP #:\u00a0A2024 11\u2013008-Y1-A0).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the contents of this manuscript and provided consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}